Lipopolysaccharides: from Erinyes to Charites
- PMID: 22665953
- PMCID: PMC3361297
- DOI: 10.1155/2012/684274
Lipopolysaccharides: from Erinyes to Charites
Abstract
Following the discovery of endotoxins by Richard Pfeiffer, such bacterial product was associated to many severe disorders produced by an overwhelming inflammatory response and often resulting in endotoxic shock and multiple organ failure. However, recent clinical and basic sciences investigations claimed some beneficial roles of typical as well as atypical endotoxins. The aim of this paper is to focus on recent data supporting a beneficial activity of both typical and atypical endotoxins. Such novel perspective looks promising for development of new drugs for prevention and therapy of several human diseases.
Figures
References
-
- Dixon-Kennedy M. Encyclopedia of Greco-Roman Mythology. Santa Barbara, Calif, USA: ABC-CLIO; 1998.
-
- Kabanov DS, Prokhorenko IR. Structural analysis of lipopolysaccharides from gram-negative bacteria. Biochemistry. 2010;75(4):383–404. - PubMed
-
- Williams KL. Historical and emerging themes. In: Williams KL, editor. Endotoxins, Pyrogens, LAL Testing and Depyrogenation. New York, NY, USA: Eli Lilly & Company; 2007.
-
- Matera G, Liberto MC, Pollio A, et al. Extraction and characterization of the lipopolysaccaride of Bartonella quintana . Infezioni in Medicina. 1999;7(2):105–107. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
